357 related articles for article (PubMed ID: 9547333)
1. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
2. Endocytosis and recycling of the HIV coreceptor CCR5.
Signoret N; Pelchen-Matthews A; Mack M; Proudfoot AE; Marsh M
J Cell Biol; 2000 Dec; 151(6):1281-94. PubMed ID: 11121442
[TBL] [Abstract][Full Text] [Related]
3. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
[TBL] [Abstract][Full Text] [Related]
6. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
Mosier DE; Picchio GR; Gulizia RJ; Sabbe R; Poignard P; Picard L; Offord RE; Thompson DA; Wilken J
J Virol; 1999 May; 73(5):3544-50. PubMed ID: 10196243
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of CC chemokine receptors by AOP-RANTES.
Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
[TBL] [Abstract][Full Text] [Related]
8. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
9. Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation.
Rusconi S; La Seta-Catamancio S; Kurtagic S; Galazzi M; Arienti D; Trabattoni D; Wilken J; Thompson DA; Offord RE; Galli M; Clerici M
AIDS Res Hum Retroviruses; 1999 Jul; 15(10):861-7. PubMed ID: 10408722
[TBL] [Abstract][Full Text] [Related]
10. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.
Hartley O; Gaertner H; Wilken J; Thompson D; Fish R; Ramos A; Pastore C; Dufour B; Cerini F; Melotti A; Heveker N; Picard L; Alizon M; Mosier D; Kent S; Offord R
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16460-5. PubMed ID: 15545608
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
Simmons G; Clapham PR; Picard L; Offord RE; Rosenkilde MM; Schwartz TW; Buser R; Wells TN; Proudfoot AE
Science; 1997 Apr; 276(5310):276-9. PubMed ID: 9092481
[TBL] [Abstract][Full Text] [Related]
12. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
[TBL] [Abstract][Full Text] [Related]
13. Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.
Sabbe R; Picchio GR; Pastore C; Chaloin O; Hartley O; Offord R; Mosier DE
J Virol; 2001 Jan; 75(2):661-71. PubMed ID: 11134280
[TBL] [Abstract][Full Text] [Related]
14. The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking.
Kiss DL; Longden J; Fechner GA; Avery VM
Cell Mol Biol Lett; 2009; 14(4):537-47. PubMed ID: 19448977
[TBL] [Abstract][Full Text] [Related]
15. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
[TBL] [Abstract][Full Text] [Related]
16. Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES.
Pastore C; Picchio GR; Galimi F; Fish R; Hartley O; Offord RE; Mosier DE
Antimicrob Agents Chemother; 2003 Feb; 47(2):509-17. PubMed ID: 12543651
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
[TBL] [Abstract][Full Text] [Related]
18. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex.
Vila-Coro AJ; Mellado M; Martín de Ana A; Martínez-A C; Rodríguez-Frade JM
J Immunol; 1999 Sep; 163(6):3037-44. PubMed ID: 10477567
[TBL] [Abstract][Full Text] [Related]
19. Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages.
Münch J; Ständker L; Pöhlmann S; Baribaud F; Papkalla A; Rosorius O; Stauber R; Sass G; Heveker N; Adermann K; Escher S; Klüver E; Doms RW; Forssmann WG; Kirchhoff F
Antimicrob Agents Chemother; 2002 Apr; 46(4):982-90. PubMed ID: 11897579
[TBL] [Abstract][Full Text] [Related]
20. Analyses of anti-HIV type 1 activity of a small CCR5 peptide antagonist.
Wang FY; He SY; Zhang ZJ; He LF; Chen XW; Teng T
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1111-5. PubMed ID: 21375388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
